Cannabinoid Isolation via Protected Amino Acid Esters
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating THC and CBD from Cannabis are expensive, inefficient, and struggle to achieve high purity, especially at large scales, and do not effectively bypass the first-pass effect or minimize side effects associated with oral administration.
Innovation Solution
A scalable process involving the preparation of t-boc-protected amino acid esters followed by normal phase chromatography, which allows for high-yield and cost-effective isolation of cannabinoids, including THC and CBD, with subsequent mild basic hydrolysis to achieve >98% purity, enabling the production of pharmaceutical-grade cannabinoids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If THC is isolated using traditional synthetic processes or conventional extraction methods, then pharmaceutical-grade purity can be achieved, but the production cost becomes excessively high and scalability is limited
Solution Approach 1:
The patent applies extraction by isolating cannabinoids directly from Cannabis plant material using supercritical fluid extraction with CO2, followed by winterization and chromatography. This natural extraction approach replaces expensive synthetic processes while achieving pharmaceutical-grade purity through systematic separation techniques
Solution Approach 2:
The patent utilizes parameter changes by adjusting temperature, pressure, and solvent composition during supercritical fluid extraction and chromatography processes. These parameter optimizations enable high-yield extraction with improved purity and reduced production costs at commercial scale
2Ease of operation
If oral THC formulation is used to deliver the active ingredient, then administration is simple, but erratic absorption and first-pass metabolism cause inconsistent bioavailability and side effects
Solution Approach 1:
The patent employs fatty acid esters of cannabinoids as intermediary compounds that can be formulated in edibles, beverages, or topicals. These ester prodrugs provide more consistent and predictable pharmacokinetic profiles compared to direct THC administration, reducing first-pass metabolism effects while maintaining ease of administration
Solution Approach 2:
The patent modifies the chemical structure of cannabinoids by creating fatty acid esters with different pharmacokinetic properties. This structural parameter change enables controlled release and improved bioavailability consistency while maintaining administration convenience
3Manufacturing precision
If conventional chromatography methods are used for cannabinoid separation, then purification can be achieved, but the process is time-consuming and not suitable for large-scale production
Solution Approach 1:
The patent applies preliminary action by performing winterization before chromatography to remove waxes, fats, and lipids from the extract. This pre-purification step reduces the complexity of the subsequent chromatography process, enabling faster separation and making the overall process suitable for large-scale production while maintaining high purity
Solution Approach 2:
The patent segments the purification process into distinct stages: supercritical fluid extraction, winterization, and chromatography. This segmentation allows each step to be optimized independently for both purity and productivity, with the chromatography step specifically optimized using standardized protocols for rapid large-scale separation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a cost-effective and efficient means to produce high-purity THC and CBD, suitable for large-scale production, while avoiding the first-pass effect and minimizing side effects, and can be adapted for other cannabinoids like THCV and CBG.
Implementation Method 1
extracting the plant material using optionally an organic solvent of supercritical fluid
Implementation Method 2
purifying the derivatized extract using normal phase column chromatography to isolate individual esters of different cannabinoids
Implementation Method 3
base hydrolyzing the isolated individual cannabinoid ester to regenerate the free cannabinoid with high purity
Data Source
AI summary
Δ9-Tetrahydrocannabinol (Δ9-THC or THC) and cannabidiol (CBD) are major constituents of the Cannabis plant that have pharmacological properties with potential therapeutic value. This invention is directed to processes for large scale isolation of these two and other cannabinoids from the Cannabis sativa plant. This is accomplished through the discovery that protected amino acid esters of the cannabinoids are easier to separate using normal phase silica column chromatography. Mild base hydrolysis of the esters regenerates the free cannabinoids in a purified form. The invention is also applicable to the isolation of other cannabinoids from Cannabis extracts.